PACLITAXEL (AIBUMIN-BOUND)

PACLITAXEL (AIBUMIN-BOUND) was reported 84326 times

PACLITAXEL (AIBUMIN-BOUND) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COMPUTERISED TOMOGRAM THORAX 39 0.6500
1 PSEUDOCIRRHOSIS 132 0.3976
2 UROGENITAL FISTULA 63 0.2658
3 CERVIX CARCINOMA RECURRENT 46 0.2584
4 IMMUNE-MEDIATED HYPERTHYROIDISM 57 0.2244
5 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 173 0.2171
6 PIK3CA-ACTIVATED MUTATION 72 0.2169
7 NAIL TOXICITY 63 0.2100
8 HER2 POSITIVE BREAST CANCER 70 0.1867
9 IMMUNE-MEDIATED HYPOTHYROIDISM 177 0.1569
10 HEPATIC ATROPHY 68 0.1518
11 IMMUNE-MEDIATED DERMATITIS 153 0.1518
12 IMMUNE-MEDIATED HYPOPHYSITIS 63 0.1397
13 IMMUNE-MEDIATED PANCREATITIS 49 0.1286
14 IMMUNE-MEDIATED LUNG DISEASE 230 0.1260
15 DELUSION OF GRANDEUR 56 0.1247
16 METASTASES TO THE MEDIASTINUM 50 0.1214
17 RADIATION OESOPHAGITIS 46 0.1207
18 GLUCOCORTICOID DEFICIENCY 50 0.1182
19 COMPUTERISED TOMOGRAM THORAX ABNORMAL 80 0.1164
20 IMMUNE-MEDIATED HEPATIC DISORDER 226 0.1158
21 IMMUNE-MEDIATED THYROIDITIS 55 0.1113
22 CYSTOID MACULAR OEDEMA 209 0.1108
23 IMMUNE-MEDIATED HEPATITIS 218 0.1067
24 HEART FAILURE WITH REDUCED EJECTION FRACTION 57 0.1065
25 IMMUNE-MEDIATED ENCEPHALITIS 56 0.1059
26 MYELOSUPPRESSION 3678 0.1020
27 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 89 0.1014
28 BRONCHOPLEURAL FISTULA 38 0.1011
29 MYOCARDIAL INJURY 111 0.0987
30 ONYCHOLYSIS 154 0.0985
31 METASTASES TO PLEURA 103 0.0982
32 IMMUNE-MEDIATED NEPHRITIS 46 0.0981
33 METASTASES TO SKIN 101 0.0978
34 INFUSION RELATED HYPERSENSITIVITY REACTION 58 0.0965
35 IMMUNE-MEDIATED RENAL DISORDER 39 0.0942
36 PERIPHERAL SENSORY NEUROPATHY 544 0.0930
37 ACUTE PROMYELOCYTIC LEUKAEMIA 94 0.0914
38 TRIPLE NEGATIVE BREAST CANCER 61 0.0906
39 OVARIAN CANCER METASTATIC 76 0.0894
40 RADIATION PNEUMONITIS 187 0.0873
41 OVARIAN CANCER RECURRENT 137 0.0852
42 METASTASES TO PERITONEUM 214 0.0847
43 IMMUNE-MEDIATED ENTEROCOLITIS 305 0.0829
44 IMMUNE-MEDIATED MYOCARDITIS 130 0.0804
45 RECALL PHENOMENON 65 0.0778
46 GRANULOCYTE COUNT DECREASED 139 0.0749
47 LYMPHANGIOSIS CARCINOMATOSA 74 0.0710
48 DILATED CARDIOMYOPATHY 70 0.0692
49 METASTASES TO MENINGES 156 0.0685
50 NAIL DYSTROPHY 38 0.0679
51 AORTITIS 46 0.0671
52 RECTAL PERFORATION 35 0.0649
53 NON-SMALL CELL LUNG CANCER 310 0.0647
54 HAEMATOTOXICITY 599 0.0630
55 METASTASES TO LYMPH NODES 414 0.0613
56 TUMOUR NECROSIS 63 0.0596
57 ALVEOLITIS 84 0.0594
58 THERAPY PARTIAL RESPONDER 926 0.0593
59 SKIN TOXICITY 334 0.0590
60 POLYNEUROPATHY 707 0.0590
61 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 73 0.0586
62 HYPOPHYSITIS 117 0.0581
63 SUPERIOR VENA CAVA SYNDROME 35 0.0579
64 METASTASES TO LIVER 1019 0.0579
65 RADIATION SKIN INJURY 67 0.0578
66 GASTROINTESTINAL PERFORATION 239 0.0574
67 METASTASES TO LUNG 661 0.0572
68 PERIPHERAL MOTOR NEUROPATHY 80 0.0571
69 CARBOHYDRATE ANTIGEN 15-3 INCREASED 43 0.0565
70 LICHENOID KERATOSIS 129 0.0564
71 NON-SMALL CELL LUNG CANCER METASTATIC 49 0.0557
72 BREAST CANCER RECURRENT 173 0.0547
73 METASTASES TO BONE 897 0.0546
74 BREAST CANCER METASTATIC 586 0.0545
75 SENSE OF OPPRESSION 64 0.0544
76 MALIGNANT PERITONEAL NEOPLASM 32 0.0541
77 FEMALE GENITAL TRACT FISTULA 92 0.0538
78 HYPOPITUITARISM 92 0.0528
79 METASTASES TO CENTRAL NERVOUS SYSTEM 668 0.0517
80 BILIARY TRACT INFECTION 32 0.0514
81 LYMPHOCYTE COUNT ABNORMAL 57 0.0506
82 FULMINANT TYPE 1 DIABETES MELLITUS 52 0.0504
83 IMMUNE-MEDIATED ADVERSE REACTION 77 0.0501
84 SUBCLAVIAN VEIN THROMBOSIS 57 0.0500
85 GASTROINTESTINAL TOXICITY 239 0.0497
86 ANASTOMOTIC LEAK 34 0.0490
87 METASTASES TO ADRENALS 45 0.0488
88 DEVICE RELATED THROMBOSIS 48 0.0487
89 FEBRILE NEUTROPENIA 3176 0.0478
90 TUMOUR PSEUDOPROGRESSION 52 0.0475
91 HYPERSENSITIVITY PNEUMONITIS 54 0.0474
92 INVASIVE DUCTAL BREAST CARCINOMA 127 0.0467
93 HAND DERMATITIS 32 0.0462
94 MALIGNANT ASCITES 35 0.0456
95 SQUAMOUS CELL CARCINOMA OF LUNG 35 0.0456
96 NEUTROPENIC SEPSIS 318 0.0445
97 NEUTROPENIC COLITIS 92 0.0444
98 ENTEROCOLITIS INFECTIOUS 41 0.0444
99 SMALL INTESTINAL PERFORATION 83 0.0442
100 THYROIDITIS 130 0.0432
101 MALIGNANT PLEURAL EFFUSION 73 0.0432
102 PULMONARY HYPOPLASIA 34 0.0431
103 PNEUMONITIS 1175 0.0431
104 CARDIAC DYSFUNCTION 159 0.0427
105 CAPILLARY LEAK SYNDROME 88 0.0425
106 LYMPHADENOPATHY MEDIASTINAL 81 0.0423
107 ACUTE MYELOID LEUKAEMIA 651 0.0417
108 NEUTROPHIL COUNT DECREASED 1695 0.0415
109 RADIOTHERAPY 78 0.0408
110 CARDIOTOXICITY 362 0.0405
111 TUMOUR HAEMORRHAGE 115 0.0403
112 PALMAR ERYTHEMA 46 0.0399
113 CHOLANGITIS SCLEROSING 82 0.0399
114 LEFT VENTRICULAR DYSFUNCTION 267 0.0398
115 CORTISOL DECREASED 44 0.0385
116 MALIGNANT NEOPLASM PROGRESSION 3938 0.0384
117 HYPERTRANSAMINASAEMIA 266 0.0382
118 SECOND PRIMARY MALIGNANCY 318 0.0382
119 HYPOPROTEINAEMIA 72 0.0379
120 MUCOSAL INFLAMMATION 988 0.0377
121 NEUROTOXICITY 660 0.0376
122 INFECTIOUS PLEURAL EFFUSION 57 0.0374
123 PELVIC ABSCESS 43 0.0374
124 NEOPLASM RECURRENCE 125 0.0368
125 HEPATITIS B REACTIVATION 117 0.0368
126 FEBRILE INFECTION 43 0.0365
127 OTOTOXICITY 67 0.0362
128 EJECTION FRACTION DECREASED 561 0.0361
129 NEUROPATHY PERIPHERAL 3433 0.0361
130 HEPATIC CYTOLYSIS 460 0.0360
131 PULMONARY TOXICITY 254 0.0359
132 MYELODYSPLASTIC SYNDROME 518 0.0358
133 DUODENAL PERFORATION 35 0.0356
134 SEROMA 45 0.0354
135 ADRENAL INSUFFICIENCY 427 0.0352
136 SECONDARY ADRENOCORTICAL INSUFFICIENCY 53 0.0351
137 FEBRILE BONE MARROW APLASIA 146 0.0343
138 NEUTROPENIA 4628 0.0340
139 SUBILEUS 70 0.0336
140 DYSAESTHESIA 103 0.0336
141 ACQUIRED GENE MUTATION 44 0.0336
142 JUGULAR VEIN THROMBOSIS 59 0.0331
143 LARGE INTESTINE PERFORATION 223 0.0321
144 BREAST NEOPLASM 33 0.0320
145 TYPE I HYPERSENSITIVITY 112 0.0318
146 EMBOLISM 259 0.0312
147 ENTEROCOLITIS 180 0.0311
148 LEUKOPENIA 1556 0.0311
149 HYPERAEMIA 61 0.0309
150 METASTASES TO SPINE 104 0.0309
151 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 715 0.0306
152 MYOCARDITIS 347 0.0302
153 STRESS CARDIOMYOPATHY 176 0.0302
154 PERIPHERAL SENSORIMOTOR NEUROPATHY 38 0.0302
155 PROTEINURIA 575 0.0302
156 METASTATIC NEOPLASM 129 0.0299
157 OXYGEN THERAPY 49 0.0298
158 PARONYCHIA 130 0.0296
159 SYSTEMIC INFECTION 49 0.0295
160 BONE MARROW TOXICITY 35 0.0295
161 DISEASE PROGRESSION 3478 0.0294
162 MASTECTOMY 51 0.0291
163 NEOPLASM PROGRESSION 1008 0.0290
164 ENCEPHALITIS AUTOIMMUNE 38 0.0289
165 TUMOUR PAIN 38 0.0288
166 HYPOTHALAMO-PITUITARY DISORDER 42 0.0288
167 INTERSTITIAL LUNG DISEASE 1385 0.0286
168 BICYTOPENIA 56 0.0285
169 BILE DUCT STENOSIS 34 0.0284
170 HYPOMAGNESAEMIA 393 0.0282
171 KOUNIS SYNDROME 64 0.0282
172 LUNG ADENOCARCINOMA 84 0.0279
173 CHOLANGITIS 173 0.0279
174 VENA CAVA THROMBOSIS 46 0.0277
175 BONE MARROW FAILURE 552 0.0271
176 METASTASIS 192 0.0269
177 PNEUMOCYSTIS JIROVECII PNEUMONIA 264 0.0263
178 MONOCYTE COUNT DECREASED 32 0.0262
179 LARYNGOSPASM 70 0.0260
180 THROMBOTIC MICROANGIOPATHY 249 0.0255
181 HYPERPYREXIA 108 0.0255
182 HYPOALBUMINAEMIA 198 0.0254
183 ANAPHYLACTIC SHOCK 656 0.0254
184 OVARIAN CANCER 234 0.0254
185 EMPYEMA 50 0.0251
186 LUNG ABSCESS 52 0.0248
187 ERYTHEMA MULTIFORME 230 0.0246
188 ADENOCARCINOMA 55 0.0245
189 BREAST DISORDER 50 0.0245
190 HYDRONEPHROSIS 183 0.0244
191 ASPARTATE AMINOTRANSFERASE ABNORMAL 37 0.0243
192 PNEUMATOSIS INTESTINALIS 69 0.0242
193 HYPOTHYROIDISM 765 0.0239
194 AUTOIMMUNE HAEMOLYTIC ANAEMIA 82 0.0239
195 CANCER PAIN 61 0.0238
196 RECURRENT CANCER 96 0.0235
197 GASTRIC PERFORATION 64 0.0235
198 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 175 0.0233
199 PSEUDOMEMBRANOUS COLITIS 52 0.0233
200 ATELECTASIS 225 0.0233
201 VENOUS THROMBOSIS LIMB 48 0.0232
202 OLIGOHYDRAMNIOS 77 0.0231
203 PERIODONTITIS 50 0.0231
204 ADRENOCORTICAL INSUFFICIENCY ACUTE 45 0.0230
205 OSTEOLYSIS 47 0.0230
206 ALANINE AMINOTRANSFERASE ABNORMAL 48 0.0227
207 EMBOLISM VENOUS 69 0.0227
208 OESOPHAGITIS 247 0.0226
209 NEPHRITIS 75 0.0224
210 NAIL DISORDER 196 0.0224
211 SUFFOCATION FEELING 55 0.0222
212 IMMUNE-MEDIATED MYOSITIS 61 0.0221
213 NAIL DISCOLOURATION 87 0.0221
214 NEUTROPHIL COUNT ABNORMAL 62 0.0219
215 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 209 0.0219
216 LYMPHOEDEMA 151 0.0218
217 PANCREATIC CARCINOMA METASTATIC 62 0.0218
218 BRONCHOSPASM 311 0.0218
219 THROMBOCYTOPENIA 2436 0.0218
220 HEPATIC FUNCTION ABNORMAL 809 0.0217
221 LYMPHOPENIA 303 0.0214
222 BONE LESION 77 0.0213
223 TUMOUR LYSIS SYNDROME 187 0.0212
224 IMMUNE THROMBOCYTOPENIA 97 0.0212
225 ANAEMIA 4036 0.0211
226 ANAPHYLACTOID REACTION 86 0.0209
227 ASCITES 614 0.0209
228 HYPOXIA 735 0.0209
229 PNEUMOTHORAX 330 0.0208
230 PORTAL HYPERTENSION 64 0.0207
231 WOUND DEHISCENCE 70 0.0207
232 GENE MUTATION 41 0.0207
233 DYSPNOEA AT REST 60 0.0207
234 CELL DEATH 41 0.0207
235 VOCAL CORD PARALYSIS 37 0.0206
236 INTESTINAL PERFORATION 231 0.0206
237 VENOUS THROMBOSIS 79 0.0201
238 TUMOUR MARKER INCREASED 96 0.0200
239 HAEMOLYTIC URAEMIC SYNDROME 46 0.0198
240 MYOSITIS 178 0.0198
241 PERFORMANCE STATUS DECREASED 92 0.0197
242 HYPERTHYROIDISM 285 0.0197
243 ILEUS 244 0.0196
244 CACHEXIA 101 0.0196
245 CARCINOEMBRYONIC ANTIGEN INCREASED 38 0.0196
246 AZOTAEMIA 78 0.0195
247 HEPATIC LESION 84 0.0194
248 ORGANISING PNEUMONIA 96 0.0194
249 PULSE ABSENT 92 0.0193
250 INFUSION RELATED REACTION 1281 0.0193
251 TYPE 1 DIABETES MELLITUS 116 0.0192
252 PANCYTOPENIA 1076 0.0192
253 DERMATITIS ACNEIFORM 117 0.0192
254 ADRENAL DISORDER 36 0.0187
255 SCLERODERMA 68 0.0187
256 SUSPECTED OFF LABEL USE 84 0.0186
257 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 33 0.0185
258 CATHETER SITE INFECTION 70 0.0185
259 HYPOKALAEMIA 850 0.0184
260 PNEUMOPERITONEUM 34 0.0184
261 JAUNDICE CHOLESTATIC 65 0.0184
262 RASH MACULO-PAPULAR 409 0.0184
263 TOXIC SKIN ERUPTION 185 0.0183
264 DISSEMINATED INTRAVASCULAR COAGULATION 258 0.0183
265 RHINALGIA 50 0.0182
266 COLITIS 685 0.0181
267 APLASIA 35 0.0179
268 MIXED LIVER INJURY 53 0.0176
269 CYSTITIS HAEMORRHAGIC 71 0.0176
270 ARTERIAL THROMBOSIS 34 0.0176
271 DERMATOMYOSITIS 44 0.0174
272 URINARY TRACT OBSTRUCTION 41 0.0173
273 HEPATOTOXICITY 383 0.0172
274 GASTROINTESTINAL NECROSIS 50 0.0171
275 LIVER ABSCESS 55 0.0169
276 MUCOSAL DRYNESS 34 0.0169
277 ENDOMETRIAL CANCER 37 0.0168
278 TROPONIN INCREASED 127 0.0167
279 CARDIOMYOPATHY 245 0.0166
280 LYMPHOCYTE COUNT DECREASED 290 0.0164
281 DERMATITIS BULLOUS 118 0.0163
282 DRUG ERUPTION 288 0.0162
283 CYANOSIS 254 0.0161
284 ENCEPHALITIS 111 0.0160
285 FLUSHING 1623 0.0159
286 GUILLAIN-BARRE SYNDROME 77 0.0159
287 INTESTINAL ISCHAEMIA 86 0.0156
288 AGRANULOCYTOSIS 289 0.0155
289 FOETAL GROWTH RESTRICTION 94 0.0154
290 TRANSAMINASES INCREASED 342 0.0154
291 HYPERTRIGLYCERIDAEMIA 90 0.0154
292 HYPERBILIRUBINAEMIA 159 0.0153
293 OXYGEN SATURATION DECREASED 862 0.0153
294 SEPTIC SHOCK 667 0.0153
295 ESCHERICHIA BACTERAEMIA 36 0.0153
296 PNEUMOCYSTIS JIROVECI PNEUMONIA 34 0.0152
297 PLEURAL EFFUSION 923 0.0152
298 MULTIPLE-DRUG RESISTANCE 47 0.0151
299 NEUTROPHIL COUNT INCREASED 154 0.0150
300 CARBOHYDRATE ANTIGEN 125 INCREASED 51 0.0149
301 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 153 0.0149
302 CYTOPENIA 182 0.0148
303 CARDIAC FAILURE ACUTE 99 0.0148
304 VASCULAR DEVICE INFECTION 67 0.0148
305 CEREBRAL ISCHAEMIA 76 0.0148
306 EXPOSED BONE IN JAW 32 0.0148
307 NEPHROTIC SYNDROME 101 0.0147
308 ARTERIOSPASM CORONARY 59 0.0147
309 AUTOIMMUNE HEPATITIS 102 0.0147
310 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 39 0.0147
311 ACUTE RESPIRATORY DISTRESS SYNDROME 259 0.0146
312 WHITE BLOOD CELL COUNT DECREASED 1583 0.0146
313 HYPERTENSIVE CRISIS 162 0.0145
314 SMALL INTESTINAL OBSTRUCTION 178 0.0144
315 OESOPHAGEAL STENOSIS 41 0.0144
316 GRANULOCYTOPENIA 82 0.0144
317 TOXIC EPIDERMAL NECROLYSIS 217 0.0143
318 DRUG RESISTANCE 366 0.0142
319 HYPOCALCAEMIA 269 0.0142
320 AUTOIMMUNE THYROIDITIS 53 0.0140
321 CYTOKINE RELEASE SYNDROME 281 0.0140
322 RENAL TUBULAR DISORDER 39 0.0138
323 ABDOMINAL INFECTION 35 0.0137
324 HAEMOPTYSIS 381 0.0136
325 ANAPHYLACTIC REACTION 751 0.0136
326 PERICARDIAL EFFUSION 314 0.0136
327 GENERAL PHYSICAL HEALTH DETERIORATION 1565 0.0135
328 TYPE IV HYPERSENSITIVITY REACTION 37 0.0135
329 PYELONEPHRITIS 117 0.0135
330 HYPERTHERMIA 103 0.0135
331 HEPATITIS 345 0.0135
332 ENTERITIS 86 0.0134
333 CONGESTIVE CARDIOMYOPATHY 56 0.0134
334 HEPATIC FAILURE 405 0.0134
335 EXTRAVASATION 55 0.0134
336 MACULAR OEDEMA 75 0.0134
337 LEFT VENTRICULAR FAILURE 46 0.0133
338 PROTEIN TOTAL DECREASED 50 0.0133
339 DRUG TOLERANCE DECREASED 37 0.0132
340 HEPATITIS FULMINANT 39 0.0131
341 STOMATITIS 797 0.0131
342 HYPONATRAEMIA 739 0.0131
343 ESCHERICHIA SEPSIS 38 0.0131
344 ASPARTATE AMINOTRANSFERASE INCREASED 692 0.0130
345 DEVICE RELATED INFECTION 200 0.0130
346 PLATELET COUNT DECREASED 1383 0.0130
347 HEPATITIS ACUTE 84 0.0129
348 LUNG OPACITY 34 0.0129
349 KERATITIS 39 0.0128
350 UROSEPSIS 118 0.0128
351 BLOOD MAGNESIUM DECREASED 110 0.0127
352 ALANINE AMINOTRANSFERASE INCREASED 782 0.0127
353 DIASTOLIC DYSFUNCTION 39 0.0126
354 CHEST DISCOMFORT 1285 0.0125
355 FAILURE TO THRIVE 65 0.0125
356 THROMBOTIC THROMBOCYTOPENIC PURPURA 44 0.0125
357 LUNG INFILTRATION 110 0.0124
358 RENAL FAILURE CHRONIC 95 0.0123
359 HYPOVOLAEMIA 72 0.0123
360 THROMBOPHLEBITIS 43 0.0123
361 HYPOPHOSPHATAEMIA 90 0.0122
362 LUNG CONSOLIDATION 34 0.0121
363 COLITIS ISCHAEMIC 82 0.0121
364 PULMONARY HAEMORRHAGE 95 0.0121
365 OSTEONECROSIS OF JAW 300 0.0121
366 DISEASE RECURRENCE 576 0.0121
367 GAMMA-GLUTAMYLTRANSFERASE INCREASED 267 0.0120
368 EPISTAXIS 901 0.0120
369 NASAL DISORDER 32 0.0120
370 CERVIX CARCINOMA 47 0.0120
371 PATHOLOGICAL FRACTURE 61 0.0120
372 ACUTE HEPATIC FAILURE 164 0.0120
373 HYPOVOLAEMIC SHOCK 57 0.0119
374 ENDOCARDITIS 61 0.0119
375 BACTERAEMIA 141 0.0119
376 NEPHROPATHY TOXIC 132 0.0117
377 BLOOD PRESSURE SYSTOLIC DECREASED 53 0.0116
378 BONE MARROW DISORDER 35 0.0116
379 CHOLESTASIS 221 0.0115
380 CARDIAC TAMPONADE 54 0.0114
381 ACUTE LYMPHOCYTIC LEUKAEMIA 32 0.0113
382 ELECTROLYTE IMBALANCE 131 0.0113
383 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 43 0.0112
384 FIBRIN D DIMER INCREASED 40 0.0112
385 LIVER INJURY 276 0.0112
386 ACUTE PULMONARY OEDEMA 63 0.0112
387 ODYNOPHAGIA 67 0.0112
388 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 87 0.0112
389 FISTULA 125 0.0111
390 BLOOD ALKALINE PHOSPHATASE INCREASED 272 0.0109
391 TUBULOINTERSTITIAL NEPHRITIS 205 0.0109
392 FEELING HOT 665 0.0108
393 AMYLASE INCREASED 40 0.0108
394 OESOPHAGEAL CANDIDIASIS 43 0.0108
395 PERIPHERAL ISCHAEMIA 44 0.0108
396 TACHYPNOEA 146 0.0107
397 DRUG-INDUCED LIVER INJURY 336 0.0107
398 RESPIRATORY FAILURE 779 0.0107
399 BLOOD BILIRUBIN INCREASED 288 0.0107
400 UNRESPONSIVE TO STIMULI 273 0.0106
401 PULMONARY EMBOLISM 1005 0.0106
402 CLOSTRIDIUM DIFFICILE COLITIS 112 0.0106
403 ONYCHOMADESIS 44 0.0105
404 ABDOMINAL ABSCESS 46 0.0104
405 PNEUMONIA BACTERIAL 95 0.0103
406 DUODENAL ULCER 73 0.0103
407 SUPRAVENTRICULAR TACHYCARDIA 99 0.0103
408 ILEUS PARALYTIC 46 0.0103
409 LARYNGEAL OEDEMA 63 0.0102
410 BLEPHARITIS 41 0.0102
411 HYPERURICAEMIA 42 0.0102
412 LOW BIRTH WEIGHT BABY 81 0.0102
413 THROAT TIGHTNESS 275 0.0102
414 TACHYCARDIA 901 0.0101
415 NON-CARDIAC CHEST PAIN 32 0.0101
416 ERYTHEMA 2051 0.0100
417 AORTIC DISSECTION 41 0.0099
418 PERITONITIS 204 0.0098
419 SINUS TACHYCARDIA 139 0.0098
420 PAPILLOEDEMA 44 0.0097
421 SEPSIS 1082 0.0097
422 LEUKOCYTOSIS 175 0.0097
423 STAPHYLOCOCCAL BACTERAEMIA 42 0.0097
424 ACUTE RESPIRATORY FAILURE 185 0.0096
425 MACULOPATHY 34 0.0096
426 CARDIAC FAILURE 767 0.0095
427 SUDDEN DEATH 101 0.0095
428 ATRIAL FLUTTER 76 0.0095
429 IMMUNOSUPPRESSION 84 0.0095
430 MALNUTRITION 106 0.0095
431 SHOCK HAEMORRHAGIC 77 0.0094
432 SKIN NECROSIS 49 0.0094
433 ESCHERICHIA URINARY TRACT INFECTION 40 0.0094
434 CHOLECYSTITIS 112 0.0094
435 ERYSIPELAS 47 0.0093
436 PYREXIA 3235 0.0093
437 RESPIRATORY DISTRESS 258 0.0093
438 HAEMOGLOBIN ABNORMAL 60 0.0093
439 HEPATOCELLULAR INJURY 132 0.0093
440 BLOOD PHOSPHORUS DECREASED 34 0.0093
441 MENINGITIS 62 0.0093
442 BLOOD CREATININE ABNORMAL 32 0.0092
443 DERMATITIS EXFOLIATIVE GENERALISED 32 0.0092
444 NECROSIS 51 0.0092
445 NEONATAL RESPIRATORY DISTRESS SYNDROME 32 0.0090
446 HAEMOLYTIC ANAEMIA 81 0.0090
447 VENTRICULAR ARRHYTHMIA 33 0.0090
448 SHOCK 207 0.0090
449 EPIGASTRIC DISCOMFORT 35 0.0090
450 MENINGITIS ASEPTIC 40 0.0089
451 RETINOPATHY 33 0.0088
452 ACUTE CORONARY SYNDROME 73 0.0088
453 AFFECTIVE DISORDER 69 0.0088
454 MULTIPLE ORGAN DYSFUNCTION SYNDROME 247 0.0087
455 BLOOD ALBUMIN DECREASED 69 0.0087
456 HYPERTENSION 1840 0.0087
457 ESCHERICHIA INFECTION 71 0.0086
458 PULMONARY FIBROSIS 165 0.0086
459 DERMATITIS EXFOLIATIVE 43 0.0086
460 LEUKOENCEPHALOPATHY 32 0.0086
461 SKIN REACTION 121 0.0086
462 BLOOD THYROID STIMULATING HORMONE DECREASED 39 0.0086
463 GENERALISED OEDEMA 106 0.0086
464 HYPERGLYCAEMIA 311 0.0085
465 MYOCARDIAL ISCHAEMIA 97 0.0085
466 HYPERCALCAEMIA 105 0.0085
467 BUNDLE BRANCH BLOCK LEFT 36 0.0085
468 ISCHAEMIA 39 0.0085
469 C-REACTIVE PROTEIN INCREASED 308 0.0085
470 COLITIS MICROSCOPIC 40 0.0084
471 BONE PAIN 494 0.0084
472 SARCOIDOSIS 40 0.0084
473 DEEP VEIN THROMBOSIS 547 0.0084
474 MITRAL VALVE INCOMPETENCE 95 0.0084
475 SKIN DISORDER 277 0.0083
476 CARDIO-RESPIRATORY ARREST 347 0.0083
477 CIRCULATORY COLLAPSE 141 0.0083
478 DYSPNOEA 4676 0.0083
479 DECREASED APPETITE 1918 0.0082
480 DEHYDRATION 1086 0.0081
481 DERMATITIS 169 0.0081
482 PULMONARY MASS 120 0.0080
483 BLOOD LACTATE DEHYDROGENASE INCREASED 127 0.0080
484 HICCUPS 65 0.0079
485 LYMPHADENOPATHY 280 0.0079
486 KLEBSIELLA INFECTION 40 0.0079
487 APLASTIC ANAEMIA 41 0.0078
488 ACUTE KIDNEY INJURY 1183 0.0077
489 INTESTINAL OBSTRUCTION 291 0.0077
490 ALTERED STATE OF CONSCIOUSNESS 167 0.0077
491 STAPHYLOCOCCAL SEPSIS 38 0.0077
492 PULMONARY ALVEOLAR HAEMORRHAGE 43 0.0077
493 CEREBRAL INFARCTION 185 0.0076
494 HYPERSENSITIVITY 1389 0.0075
495 APHTHOUS ULCER 58 0.0075
496 INFLAMMATORY MARKER INCREASED 37 0.0075
497 HAEMATOCRIT DECREASED 148 0.0075
498 ALOPECIA 1463 0.0074
499 ORAL CANDIDIASIS 98 0.0074
500 RENAL TUBULAR NECROSIS 73 0.0074
501 PEMPHIGOID 56 0.0074
502 BLOOD PRESSURE DIASTOLIC DECREASED 54 0.0073
503 FAECALOMA 40 0.0073
504 FACE OEDEMA 123 0.0073
505 HYPOTENSION 1463 0.0073
506 BLOOD THYROID STIMULATING HORMONE INCREASED 67 0.0073
507 PHLEBITIS 37 0.0072
508 DERMATITIS ALLERGIC 89 0.0071
509 DIARRHOEA HAEMORRHAGIC 66 0.0071
510 CHOLECYSTITIS ACUTE 40 0.0071
511 GINGIVITIS 38 0.0070
512 ABDOMINAL PAIN 1637 0.0070
513 HYPERNATRAEMIA 35 0.0070
514 SPINAL PAIN 82 0.0070
515 STEVENS-JOHNSON SYNDROME 155 0.0070
516 LUNG INFECTION 108 0.0069
517 BACK PAIN 1612 0.0069
518 ASTHENIA 2603 0.0069
519 PLEURISY 41 0.0069
520 METABOLIC DISORDER 40 0.0069
521 BLOOD DISORDER 55 0.0069
522 HAEMATURIA 235 0.0069
523 HAEMOGLOBIN DECREASED 704 0.0068
524 CARDIOGENIC SHOCK 98 0.0068
525 VOMITING 3198 0.0068
526 DIARRHOEA 4383 0.0068
527 DYSPNOEA EXERTIONAL 255 0.0068
528 HYPERKALAEMIA 237 0.0068
529 RASH PUSTULAR 49 0.0067
530 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 34 0.0067
531 LUNG DISORDER 329 0.0067
532 TASTE DISORDER 136 0.0067
533 ISCHAEMIC STROKE 119 0.0067
534 CONCOMITANT DISEASE AGGRAVATED 41 0.0066
535 SENSORY DISTURBANCE 106 0.0066
536 CELLULITIS 332 0.0066
537 BLOOD CREATININE INCREASED 430 0.0066
538 ENCEPHALOPATHY 161 0.0065
539 CENTRAL NERVOUS SYSTEM LESION 90 0.0065
540 GINGIVAL PAIN 52 0.0065
541 BRONCHIECTASIS 44 0.0065
542 DYSLIPIDAEMIA 33 0.0065
543 MYASTHENIA GRAVIS 52 0.0064
544 PREMATURE DELIVERY 102 0.0064
545 PANCREATITIS ACUTE 143 0.0064
546 CHOKING SENSATION 35 0.0063
547 BLOOD UREA INCREASED 106 0.0063
548 ATAXIA 75 0.0063
549 DEFAECATION URGENCY 44 0.0063
550 PREMATURE BABY 189 0.0063
551 BODY TEMPERATURE INCREASED 128 0.0063
552 POLYARTHRITIS 33 0.0063
553 DECUBITUS ULCER 51 0.0063
554 GASTROINTESTINAL DISORDER 560 0.0062
555 ASPERGILLUS INFECTION 41 0.0062
556 HYDROCEPHALUS 34 0.0062
557 RENAL IMPAIRMENT 523 0.0062
558 ANOREXIA 80 0.0062
559 PNEUMONIA ASPIRATION 155 0.0062
560 NEURALGIA 150 0.0062
561 NEUTROPHILIA 35 0.0061
562 INTRACRANIAL PRESSURE INCREASED 34 0.0061
563 BLOOD SODIUM DECREASED 115 0.0061
564 SENSORY LOSS 49 0.0061
565 NAUSEA 4733 0.0060
566 OROPHARYNGEAL DISCOMFORT 54 0.0060
567 WHITE BLOOD CELL COUNT ABNORMAL 38 0.0059
568 PSEUDOMONAS INFECTION 51 0.0059
569 MUSCULOSKELETAL CHEST PAIN 92 0.0059
570 DYSPHAGIA 564 0.0059
571 ANAL ABSCESS 32 0.0059
572 MOUTH ULCERATION 125 0.0059
573 SKIN INFECTION 66 0.0059
574 FACIAL PARALYSIS 50 0.0059
575 VENTRICULAR FIBRILLATION 65 0.0058
576 CONSTIPATION 1276 0.0058
577 PARAESTHESIA 920 0.0058
578 THYROID DISORDER 90 0.0058
579 RESPIRATORY TRACT INFECTION 152 0.0058
580 GENERALISED ERYTHEMA 33 0.0058
581 HYPERKERATOSIS 32 0.0058
582 PRESYNCOPE 141 0.0058
583 GINGIVAL BLEEDING 79 0.0058
584 CHEST PAIN 1068 0.0058
585 PROTHROMBIN TIME PROLONGED 34 0.0057
586 BRONCHOPULMONARY ASPERGILLOSIS 44 0.0057
587 ONYCHOCLASIS 39 0.0057
588 HEPATITIS CHOLESTATIC 34 0.0056
589 LIPASE INCREASED 43 0.0056
590 HEPATIC CIRRHOSIS 105 0.0056
591 HEPATIC STEATOSIS 104 0.0056
592 POST PROCEDURAL COMPLICATION 107 0.0056
593 DEPRESSED LEVEL OF CONSCIOUSNESS 220 0.0056
594 HYPOPHAGIA 142 0.0055
595 HAEMODYNAMIC INSTABILITY 42 0.0055
596 HAEMORRHAGIC STROKE 43 0.0055
597 OLIGURIA 34 0.0055
598 PARAESTHESIA ORAL 79 0.0055
599 CARDIAC ARREST 449 0.0054
600 SYNCOPE 544 0.0054
601 PNEUMONIA 1757 0.0054
602 OEDEMA PERIPHERAL 660 0.0054
603 UPPER GASTROINTESTINAL HAEMORRHAGE 91 0.0054
604 BREAST CANCER 504 0.0054
605 EYE MOVEMENT DISORDER 37 0.0054
606 VENTRICULAR EXTRASYSTOLES 56 0.0054
607 COLD SWEAT 95 0.0054
608 THERAPY NON-RESPONDER 241 0.0054
609 LIVER DISORDER 237 0.0053
610 VASCULITIS 62 0.0053
611 ORAL DISORDER 39 0.0053
612 HEPATITIS B 32 0.0053
613 NEOPLASM 61 0.0053
614 PRODUCT USE IN UNAPPROVED INDICATION 1312 0.0053
615 BLOOD PRESSURE DECREASED 351 0.0053
616 SCHIZOPHRENIA 64 0.0053
617 RED BLOOD CELL COUNT DECREASED 150 0.0052
618 HYPERHIDROSIS 675 0.0052
619 CHILLS 614 0.0052
620 SKIN ULCER 135 0.0052
621 DRUG TOXICITY 71 0.0052
622 OFF LABEL USE 4561 0.0052
623 GASTROENTERITIS 76 0.0052
624 WOUND INFECTION 57 0.0052
625 HEPATOMEGALY 51 0.0052
626 GASTRITIS 136 0.0052
627 TRICUSPID VALVE INCOMPETENCE 41 0.0052
628 BREAST PAIN 55 0.0052
629 EMPHYSEMA 52 0.0051
630 ASPHYXIA 42 0.0051
631 ATRIAL FIBRILLATION 497 0.0051
632 RASH 2212 0.0051
633 IMPAIRED HEALING 166 0.0051
634 INFECTION 730 0.0050
635 PALLOR 137 0.0050
636 LOSS OF CONSCIOUSNESS 644 0.0050
637 GENERAL PHYSICAL CONDITION ABNORMAL 34 0.0050
638 SKIN HYPERPIGMENTATION 43 0.0050
639 DYSURIA 184 0.0050
640 HYPERAESTHESIA 41 0.0050
641 BLOOD CALCIUM DECREASED 56 0.0050
642 CYSTITIS 158 0.0050
643 SKIN MASS 33 0.0049
644 HEPATIC ENCEPHALOPATHY 46 0.0049
645 HOT FLUSH 371 0.0049
646 BRAIN OEDEMA 62 0.0049
647 EPILEPSY 150 0.0049
648 URINARY TRACT INFECTION 837 0.0049
649 OEDEMA 266 0.0049
650 EYELID OEDEMA 57 0.0049
651 SQUAMOUS CELL CARCINOMA 46 0.0049
652 ORTHOSTATIC HYPOTENSION 85 0.0049
653 CLOSTRIDIUM DIFFICILE INFECTION 106 0.0049
654 PULMONARY OEDEMA 217 0.0048
655 RESPIRATORY SYNCYTIAL VIRUS INFECTION 42 0.0048
656 WHITE BLOOD CELL COUNT INCREASED 184 0.0048
657 SPINAL OSTEOARTHRITIS 42 0.0048
658 COUGH 1338 0.0048
659 URINARY INCONTINENCE 141 0.0048
660 PSYCHOLOGICAL TRAUMA 41 0.0047
661 PETECHIAE 49 0.0047
662 HAEMATEMESIS 118 0.0047
663 MYOPATHY 40 0.0046
664 DIABETIC KETOACIDOSIS 111 0.0046
665 RESPIRATORY RATE INCREASED 41 0.0046
666 JAUNDICE 124 0.0046
667 SPINAL COMPRESSION FRACTURE 38 0.0046
668 MULTI-ORGAN FAILURE 79 0.0046
669 FAECES SOFT 33 0.0045
670 HYPOAESTHESIA 676 0.0045
671 RECTAL HAEMORRHAGE 194 0.0045
672 COAGULOPATHY 75 0.0045
673 DYSGEUSIA 333 0.0045
674 FLANK PAIN 42 0.0045
675 ASPIRATION 49 0.0045
676 CONJUNCTIVITIS 83 0.0045
677 LOWER GASTROINTESTINAL HAEMORRHAGE 33 0.0045
678 FATIGUE 3475 0.0045
679 BLOOD CALCIUM INCREASED 39 0.0044
680 GASTRIC HAEMORRHAGE 51 0.0044
681 GASTRIC ULCER 84 0.0044
682 MYALGIA 750 0.0044
683 DELIRIUM 153 0.0044
684 SARS-COV-2 TEST POSITIVE 58 0.0044
685 HALLUCINATION, AUDITORY 69 0.0043
686 RHINITIS 35 0.0043
687 APHASIA 131 0.0043
688 HAEMATOMA 112 0.0043
689 SUBARACHNOID HAEMORRHAGE 44 0.0043
690 RENAL CYST 34 0.0043
691 ACUTE MYOCARDIAL INFARCTION 126 0.0043
692 RENAL FAILURE ACUTE 181 0.0043
693 BLOOD POTASSIUM DECREASED 127 0.0042
694 ABSCESS 67 0.0042
695 MATERNAL DRUGS AFFECTING FOETUS 32 0.0042
696 INCONTINENCE 44 0.0042
697 SKIN LESION 114 0.0042
698 APNOEA 32 0.0041
699 LIVER FUNCTION TEST INCREASED 88 0.0041
700 MELAENA 90 0.0041
701 PELVIC PAIN 74 0.0041
702 DRUG INTOLERANCE 392 0.0041
703 CEREBRAL HAEMORRHAGE 145 0.0040
704 MENTAL STATUS CHANGES 112 0.0040
705 OSTEOMYELITIS 73 0.0040
706 IRON DEFICIENCY ANAEMIA 37 0.0040
707 STAPHYLOCOCCAL INFECTION 132 0.0040
708 PHOTOSENSITIVITY REACTION 66 0.0040
709 NODULE 52 0.0040
710 PURPURA 35 0.0040
711 DRY THROAT 40 0.0039
712 LEUKAEMIA 37 0.0039
713 LIVER FUNCTION TEST ABNORMAL 114 0.0039
714 THROMBOSIS 314 0.0039
715 OSTEONECROSIS 128 0.0039
716 BONE DISORDER 71 0.0039
717 COVID-19 PNEUMONIA 46 0.0039
718 URINE OUTPUT DECREASED 34 0.0039
719 INTENTIONAL PRODUCT USE ISSUE 340 0.0039
720 EYELID PTOSIS 39 0.0038
721 ANURIA 33 0.0038
722 HYPOTHERMIA 38 0.0037
723 CARDIOMEGALY 46 0.0037
724 ANGINA PECTORIS 107 0.0037
725 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 265 0.0037
726 BLOOD CREATINE PHOSPHOKINASE INCREASED 106 0.0037
727 HEPATIC ENZYME INCREASED 251 0.0037
728 RASH ERYTHEMATOUS 176 0.0037
729 HAEMORRHAGE INTRACRANIAL 55 0.0037
730 TOXICITY TO VARIOUS AGENTS 614 0.0036
731 DRUG INTERACTION 576 0.0036
732 VISUAL ACUITY REDUCED 120 0.0036
733 CANDIDA INFECTION 61 0.0036
734 PULMONARY HYPERTENSION 75 0.0036
735 RESPIRATORY ARREST 99 0.0036
736 HAEMORRHOIDS 70 0.0036
737 NERVOUS SYSTEM DISORDER 112 0.0036
738 ARRHYTHMIA 168 0.0035
739 RENAL FAILURE 471 0.0035
740 DYSPHONIA 206 0.0035
741 BLOOD PRESSURE ABNORMAL 70 0.0035
742 ABDOMINAL PAIN LOWER 89 0.0035
743 SINUS BRADYCARDIA 34 0.0035
744 VERTIGO 213 0.0035
745 BLOOD PRESSURE SYSTOLIC INCREASED 68 0.0035
746 GASTROINTESTINAL HAEMORRHAGE 289 0.0035
747 FOETAL EXPOSURE DURING PREGNANCY 281 0.0035
748 PRODUCTIVE COUGH 165 0.0035
749 VENTRICULAR TACHYCARDIA 56 0.0034
750 MUSCULAR WEAKNESS 385 0.0034
751 BACTERIAL INFECTION 63 0.0034
752 RESPIRATORY DISORDER 101 0.0034
753 PERIPHERAL COLDNESS 46 0.0033
754 TOOTH ABSCESS 34 0.0033
755 NO THERAPEUTIC RESPONSE 40 0.0033
756 PERICARDITIS 55 0.0033
757 CARDIOVASCULAR DISORDER 83 0.0033
758 GENERALISED TONIC-CLONIC SEIZURE 54 0.0033
759 COGNITIVE DISORDER 152 0.0033
760 HEMIPARESIS 55 0.0032
761 SPLENOMEGALY 38 0.0032
762 MOTOR DYSFUNCTION 33 0.0032
763 MADAROSIS 37 0.0032
764 PALPITATIONS 371 0.0032
765 FEEDING DISORDER 64 0.0032
766 MICTURITION URGENCY 36 0.0031
767 MALAISE 1365 0.0031
768 DIPLOPIA 80 0.0031
769 MASS 43 0.0031
770 CYTOMEGALOVIRUS INFECTION 51 0.0031
771 PLATELET COUNT INCREASED 40 0.0031
772 BLOOD TEST ABNORMAL 43 0.0031
773 LOWER RESPIRATORY TRACT INFECTION 139 0.0031
774 TOOTH EXTRACTION 38 0.0031
775 ECZEMA 159 0.0030
776 ORAL PAIN 68 0.0030
777 MATERNAL EXPOSURE DURING PREGNANCY 269 0.0030
778 FRACTURE 57 0.0030
779 ELECTROCARDIOGRAM QT PROLONGED 108 0.0030
780 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 164 0.0030
781 TOOTHACHE 54 0.0030
782 EXTRAPYRAMIDAL DISORDER 74 0.0030
783 DISORIENTATION 117 0.0029
784 MUSCULOSKELETAL PAIN 153 0.0029
785 CAESAREAN SECTION 34 0.0029
786 DYSPEPSIA 285 0.0029
787 PRURITUS 1112 0.0029
788 UVEITIS 39 0.0029
789 SEIZURE 332 0.0029
790 ORAL HERPES 56 0.0029
791 INFLAMMATION 148 0.0029
792 WEIGHT DECREASED 799 0.0029
793 ABDOMINAL PAIN UPPER 587 0.0028
794 METABOLIC ACIDOSIS 91 0.0028
795 HYPERLIPIDAEMIA 34 0.0028
796 IMMUNODEFICIENCY 42 0.0028
797 SKIN FISSURES 55 0.0028
798 RHABDOMYOLYSIS 116 0.0028
799 TREATMENT FAILURE 230 0.0028
800 RESPIRATORY DEPRESSION 34 0.0028
801 BLOOD PRESSURE INCREASED 423 0.0028
802 DRY MOUTH 224 0.0028
803 URINARY RETENTION 92 0.0028
804 THERAPEUTIC RESPONSE DECREASED 164 0.0027
805 CARDIAC FAILURE CONGESTIVE 217 0.0027
806 INTERNATIONAL NORMALISED RATIO INCREASED 77 0.0027
807 PANCREATITIS 142 0.0027
808 GLOMERULAR FILTRATION RATE DECREASED 33 0.0027
809 DYSARTHRIA 101 0.0027
810 LETHARGY 154 0.0027
811 RIB FRACTURE 55 0.0027
812 WHEEZING 158 0.0027
813 PARALYSIS 38 0.0027
814 HYPOAESTHESIA ORAL 40 0.0027
815 CONDITION AGGRAVATED 802 0.0026
816 ARTHRALGIA 1095 0.0026
817 SKIN EXFOLIATION 222 0.0026
818 HAEMORRHAGE 270 0.0026
819 TOOTH INFECTION 34 0.0026
820 PAIN IN JAW 73 0.0026
821 UPPER RESPIRATORY TRACT INFECTION 119 0.0026
822 EAR PAIN 50 0.0026
823 RESTLESSNESS 94 0.0026
824 HEART RATE DECREASED 90 0.0026
825 HERPES ZOSTER 147 0.0026
826 PULMONARY ARTERIAL HYPERTENSION 37 0.0026
827 DEATH 2190 0.0025
828 EXPOSURE DURING PREGNANCY 157 0.0025
829 PSYCHOTIC DISORDER 74 0.0025
830 RASH PRURITIC 134 0.0025
831 ILL-DEFINED DISORDER 150 0.0025
832 DIVERTICULITIS 68 0.0025
833 ABDOMINAL DISTENSION 256 0.0024
834 CONFUSIONAL STATE 396 0.0024
835 HEART RATE INCREASED 242 0.0024
836 FEELING COLD 68 0.0024
837 EATING DISORDER 52 0.0024
838 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 70 0.0024
839 THROAT IRRITATION 107 0.0024
840 NEOPLASM MALIGNANT 159 0.0024
841 PRODUCT PRESCRIBING ISSUE 51 0.0023
842 EOSINOPHILIA 41 0.0023
843 DEAFNESS 61 0.0023
844 TINNITUS 107 0.0023
845 BRADYCARDIA 123 0.0023
846 DISCOMFORT 140 0.0023
847 ULCER 36 0.0023
848 HEART RATE IRREGULAR 51 0.0023
849 HAEMATOCHEZIA 124 0.0022
850 SNEEZING 50 0.0022
851 DIZZINESS 1108 0.0022
852 TENDONITIS 34 0.0022
853 LACRIMATION INCREASED 66 0.0022
854 PAIN IN EXTREMITY 643 0.0022
855 MUSCULOSKELETAL DISCOMFORT 37 0.0021
856 COMA 102 0.0021
857 RHINORRHOEA 136 0.0021
858 WOUND 58 0.0021
859 LIP SWELLING 69 0.0021
860 RETCHING 44 0.0021
861 COVID-19 359 0.0020
862 COLITIS ULCERATIVE 91 0.0020
863 PRODUCT USE ISSUE 382 0.0020
864 VAGINAL HAEMORRHAGE 88 0.0020
865 LUNG NEOPLASM MALIGNANT 83 0.0020
866 DRUG INEFFECTIVE 2641 0.0020
867 BLOOD TRIGLYCERIDES INCREASED 35 0.0020
868 HEAD DISCOMFORT 35 0.0020
869 DEPRESSED MOOD 104 0.0020
870 BLISTER 110 0.0020
871 TREMOR 325 0.0020
872 PRESCRIBED UNDERDOSE 39 0.0020
873 URTICARIA 325 0.0019
874 AMENORRHOEA 34 0.0019
875 RESTLESS LEGS SYNDROME 35 0.0019
876 CHOLELITHIASIS 63 0.0019
877 DISTURBANCE IN ATTENTION 103 0.0019
878 GASTROOESOPHAGEAL REFLUX DISEASE 152 0.0019
879 DRY EYE 94 0.0019
880 RASH PAPULAR 42 0.0019
881 SPINAL FRACTURE 37 0.0018
882 FULL BLOOD COUNT DECREASED 37 0.0018
883 RENAL DISORDER 85 0.0018
884 LOWER LIMB FRACTURE 35 0.0018
885 BALANCE DISORDER 156 0.0018
886 NIGHT SWEATS 58 0.0018
887 HYPOGLYCAEMIA 87 0.0018
888 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 46 0.0018
889 GASTRIC CANCER 45 0.0018
890 DIABETES MELLITUS 135 0.0018
891 NECK PAIN 98 0.0018
892 SWELLING FACE 114 0.0017
893 DRY SKIN 233 0.0017
894 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 91 0.0017
895 BRONCHITIS 129 0.0017
896 PAIN 1063 0.0017
897 POLLAKIURIA 72 0.0017
898 ADVERSE EVENT 158 0.0017
899 CONVULSION 98 0.0017
900 FUNGAL INFECTION 57 0.0017
901 PAIN OF SKIN 46 0.0017
902 LIMB DISCOMFORT 52 0.0017
903 CATARACT 99 0.0017
904 DRUG EFFECT INCOMPLETE 60 0.0017
905 MUSCLE TWITCHING 38 0.0016
906 AGITATION 121 0.0016
907 TYPE 2 DIABETES MELLITUS 55 0.0016
908 VISION BLURRED 224 0.0016
909 LABORATORY TEST ABNORMAL 48 0.0016
910 VISUAL IMPAIRMENT 201 0.0016
911 TRANSIENT ISCHAEMIC ATTACK 54 0.0016
912 OROPHARYNGEAL PAIN 148 0.0016
913 SKIN DISCOLOURATION 73 0.0016
914 HEADACHE 983 0.0016
915 GAIT INABILITY 52 0.0016
916 FEMUR FRACTURE 48 0.0015
917 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 279 0.0015
918 LACTIC ACIDOSIS 50 0.0015
919 UNDERDOSE 111 0.0015
920 MUSCLE SPASMS 279 0.0015
921 SPEECH DISORDER 79 0.0015
922 GAIT DISTURBANCE 285 0.0015
923 RASH MACULAR 52 0.0015
924 TOOTH DISORDER 33 0.0015
925 RENAL INJURY 44 0.0015
926 SWELLING 138 0.0015
927 BURNING SENSATION 103 0.0015
928 INTERVERTEBRAL DISC PROTRUSION 32 0.0015
929 MYOCARDIAL INFARCTION 254 0.0015
930 BLINDNESS 58 0.0014
931 CEREBROVASCULAR ACCIDENT 241 0.0014
932 ANGIOEDEMA 61 0.0014
933 ABDOMINAL DISCOMFORT 230 0.0014
934 SLEEP DISORDER 94 0.0013
935 INSOMNIA 348 0.0013
936 OSTEOARTHRITIS 54 0.0013
937 BREAST CANCER FEMALE 34 0.0013
938 ADVERSE DRUG REACTION 114 0.0013
939 NASAL CONGESTION 74 0.0013
940 ANXIETY 357 0.0013
941 FLATULENCE 70 0.0012
942 MOVEMENT DISORDER 39 0.0012
943 CARDIAC DISORDER 113 0.0012
944 PERIPHERAL SWELLING 186 0.0012
945 DYSSTASIA 35 0.0012
946 CORONARY ARTERY DISEASE 35 0.0012
947 SOMNOLENCE 232 0.0012
948 NASOPHARYNGITIS 210 0.0011
949 CONTRAINDICATED PRODUCT ADMINISTERED 34 0.0011
950 INFLUENZA LIKE ILLNESS 92 0.0011
951 HYPOACUSIS 48 0.0011
952 FALL 370 0.0011
953 SURGERY 64 0.0011
954 VIRAL INFECTION 36 0.0011
955 MEDICATION ERROR 58 0.0010
956 MUSCULOSKELETAL STIFFNESS 91 0.0010
957 CONTUSION 98 0.0010
958 ARTHRITIS 80 0.0010
959 OSTEOPOROSIS 40 0.0010
960 THERAPY CESSATION 49 0.0010
961 SINUSITIS 97 0.0009
962 MEMORY IMPAIRMENT 127 0.0009
963 HALLUCINATION 69 0.0009
964 TREATMENT NONCOMPLIANCE 50 0.0009
965 CHRONIC KIDNEY DISEASE 66 0.0009
966 ASTHMA 95 0.0008
967 WEIGHT INCREASED 186 0.0008
968 OVERDOSE 177 0.0008
969 MENTAL DISORDER 35 0.0008
970 BLOOD GLUCOSE INCREASED 149 0.0008
971 DEPRESSION 177 0.0008
972 MOBILITY DECREASED 55 0.0008
973 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 36 0.0007
974 FLUID RETENTION 38 0.0007
975 FEELING ABNORMAL 179 0.0007
976 AMNESIA 46 0.0007
977 INFLUENZA 70 0.0006
978 INTENTIONAL PRODUCT MISUSE 54 0.0006
979 INJURY 43 0.0006
980 THERAPY INTERRUPTED 41 0.0006
981 HOSPITALISATION 84 0.0005
982 IRRITABILITY 32 0.0005
983 SKIN BURNING SENSATION 38 0.0005
984 JOINT SWELLING 64 0.0005
985 INCORRECT DOSE ADMINISTERED 115 0.0005
986 PSORIASIS 62 0.0005
987 UNEVALUABLE EVENT 34 0.0004
988 RHEUMATOID ARTHRITIS 51 0.0004
989 NO ADVERSE EVENT 71 0.0004
990 ILLNESS 39 0.0004
991 EMOTIONAL DISTRESS 44 0.0004
992 MIGRAINE 34 0.0004
993 PRODUCT QUALITY ISSUE 43 0.0003
994 INJECTION SITE PAIN 65 0.0002
995 PRODUCT DOSE OMISSION ISSUE 38 0.0001